How have the SSRI antidepressants affected suicide risk?

Hall, W. D. (2006) How have the SSRI antidepressants affected suicide risk?. Lancet, 367 9527: 1959-1962. doi:10.1016/S0140-6736(06)68860-0


Author Hall, W. D.
Title How have the SSRI antidepressants affected suicide risk?
Journal name Lancet   Check publisher's open access policy
ISSN 0140-6736
Publication date 2006
Sub-type Article (original research)
DOI 10.1016/S0140-6736(06)68860-0
Volume 367
Issue 9527
Start page 1959
End page 1962
Total pages 4
Place of publication London
Publisher Lancet Ltd
Collection year 2006
Language eng
Subject CX
321202 Epidemiology
730306 Evaluation of health outcomes
110309 Infectious Diseases
110399 Clinical Sciences not elsewhere classified
Formatted abstract
Two conflicting claims have been made about the eff ects that the selective serotonin-reuptake inhibitor (SSRI) antidepressants have on suicide risk: that increased SSRI use has reduced suicide rates,1 and that SSRIs increase suicide risk in some patients early in treatment.2 Without a gold-standard method for arbitrating these claims, we have to look for a convergence of imperfect evidence from a range of study types (table).
Keyword Medicine, General & Internal
Serotonin Reuptake Inhibitors
Randomized Controlled-trials
Time-series Analysis
Adolescents
Depression
Metaanalysis
Association
Medication
Efficacy
Placebo
Q-Index Code CX
Additional Notes Refers to: Clinical trials in children, for children, The Lancet, Volume 367, Issue 9527, 17 June 2006-23 June 2006, Page 1953,

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 30 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 39 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 08:49:01 EST